High quality biotech news right now? BioTech Health X brings you the newest quality biotechnology news including breaking news on the latest biotechnology research, emerging companies, biotech acquisitions, funding deals and other industry analysis. We focus on covering the latest updates in biotech including clinical research, drug development, drug discovery, clinical trials, FDA decisions and other development information regarding the Life Sciences industry.
Toyobo Co., Ltd. has launched a major U.S. marketing initiative for Nerbridge TM (“the product”, hereafter), a conduit for peripheral nerve regeneration. On January 11, 2022, Toyobo kicked off the sales promotion campaign at a conference jointly held in Carlsbad, California, by three societies – the American Association for Hand Surgery (AAHS), the American Society for Peripheral Nerve (ASPN) and the American Society for Reconstructive Microsurgery (ASRM). The campaign is being conducted in partnership with the exclusive U.S. distributor of Nerbridge TM, Synovis Micro Companies Alliance, Inc. (hereafter Synovis), a subsidiary of Baxter International Inc., a global medtech leader. Toyobo plans to enhance the production capacity of the product by the end of 2025 as well as expanding the scope of its clinical applications. To respond to the increasing demand expected for nerves conduits in the U.S. and elsewhere in the world, Toyobo will strengthen its production and sales capacities, thus becoming the leading company in the nerve conduit business field.
CureDuchenne, a company committed to finding a cure for Duchenne muscular dystrophy (DMD), will be holding its FUTURES 2022 conference in Orlando, Florida this May. CureDuchenne’s mission is to extend and improve the lives of everyone affected by Duchenne muscular dystrophy,” CEO Debra Miller told BioSpace. Duchenne is a fatal and progressive muscle wasting disease. It affects primarily boys, although girls can be carriers, so it really does affect the whole family. Miller explained that the boys who suffer are typically confined to a wheelchair by the age of 12. Our mission is to fund transformative and impactful research that stands a good chance of resulting in an approved drug, she continued. We also provide support and resources to the families that are living with this disease.
From expected trial results to explaining the mechanism of action, our system of news and research that we develop has led to BioTech Health X becoming leaders in the biotechnology news industry. Beginning with pre-clinical stage companies in development to communities sharing natural product research, our website has benefits all interested in learning about the latest in biotechnology from scientists and the importance of continued growth. Discover even more details on https://biotechhealthx.com/.
Physical disability can be very traumatic for a human being. Irrespective of the cause of the disability, it has a deep psychological effect on people’s minds. Since long there have been attempts to recreate the lost limbs or legs. There are two types of passive prosthetics – static and adjustable. In recent years, adjustable passive prosthetics have gained huge popularity among people due to its superior adjustment abilities. Several recognized organizations such as the International Committee of the Red Cross are now actively participating in the production of such passive prosthetics. They are also working in spreading the awareness about the benefits of using these passive prosthetics in developing countries such as Nepal, India, China, and New Zealand among others.